Harmony Biosciences Holdings (HRMY) Interest Expenses (2019 - 2026)

Harmony Biosciences Holdings (HRMY) has 8 years of Interest Expenses data on file, last reported at $3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 81.41% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $18.9 million (up 5.89% YoY), and the FY2025 full-year result was $52.0 million, up 18.74% from the prior year.
• Interest Expenses slipped to $3.3 million in Q1 2026, from $3.5 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $72.8 million in Q3 2024 to a low of $3.3 million in Q1 2026.
• A 5-year average of $21.1 million and a median of $23.8 million in 2022 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses jumped 232.38% in 2022 and tumbled 81.41% in 2026, its largest moves.
• Tracing HRMY's Interest Expenses over 5 years: stood at $6.7 million in 2022, then increased by 17.53% to $7.9 million in 2023, then sank by 46.43% to $4.2 million in 2024, then decreased by 15.75% to $3.5 million in 2025, then slipped by 6.26% to $3.3 million in 2026.
• Business Quant data shows HRMY's Interest Expenses at $3.3 million in Q1 2026, $3.5 million in Q4 2025, and $17.9 million in Q3 2025.